MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Crocs Company Profile (NASDAQ:CROX)

Consensus Ratings for Crocs (NASDAQ:CROX) (?)
Ratings Breakdown: 4 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $16.50 (16.28% upside)

Analysts' Ratings History for Crocs (NASDAQ:CROX)
Show:
DateFirmActionRatingPrice TargetActions
8/14/2015Sterne Agee CRTReiterated RatingBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Piper JaffrayReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/3/2015B. RileyReiterated RatingNeutral$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015Sterne Agee CRTReiterated RatingBuy$16.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015Piper JaffrayReiterated RatingOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015B. RileyReiterated RatingNeutral$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/10/2015Piper JaffraySet Price TargetBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015Canaccord GenuityReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/26/2015Piper JaffrayReiterated RatingOverweight$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/20/2015B. RileyInitiated CoverageNeutral$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/14/2015Piper JaffrayUpgradeNeutral -> Overweight$13.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015WunderlichBoost Price TargetBuy$15.50 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Piper JaffrayReiterated RatingNeutral -> Hold$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Sterne Agee CRTReiterated RatingPositive$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Standpoint ResearchDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2015Piper JaffrayReiterated RatingNeutral$10.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2015Sterne Agee CRTReiterated RatingBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015Sterne Agee CRTSet Price TargetBuy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2015WunderlichLower Price TargetBuy$17.00 -> $15.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2015Monness Crespi & HardtLower Price TargetBuy$20.00 -> $17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015Piper JaffrayDowngradeOverweight -> Neutral$18.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014Sterne Agee CRTUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2014Sterne Agee CRTUpgradeNeutral -> Buy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014Piper JaffrayLower Price Target$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014WunderlichReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2014Monness Crespi & HardtReiterated RatingBuy$22.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/1/2014WunderlichInitiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/11/2014Buckingham ResearchDowngradeBuy -> Neutral$20.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/23/2014WedbushBoost Price TargetNeutral$15.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2014CL KingUpgradeNeutral -> Strong-BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2014Buckingham ResearchInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2014Piper JaffrayUpgradeNeutral -> Overweight$16.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/28/2014Piper JaffrayInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2014Monness Crespi & HardtUpgradeNeutral -> Buy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/31/2013Imperial CapitalBoost Price TargetIn-Line$14.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2013Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2013Sterne Agee CRTUpgradeUnderperform -> Neutral$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2013Goldman SachsReiterated RatingNeutral$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2013Ned Davis ResearchUpgradeNeutral -> BuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/13/2013Stifel NicolausReiterated RatingBuy$17.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/31/2013Imperial CapitalDowngradeOutperform -> In-Line$17.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2013Piper JaffrayDowngradeOverweight -> Neutral$18.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha